{
  "ptid_time": "019_S_4548_2012-02-23",
  "img_path": "/data/qiuhui/data/adni/images/019_S_4548/2012-02-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 51,225 mm³, 9.0% above the reference mean. With a Z-score of 0.26 (60.3th percentile), this represents normal volume ; whole brain volume measures 1,026,400 mm³, 0.3% below the reference mean. With a Z-score of -0.04 (48.6th percentile), this represents normal volume ; entorhinal cortex volume measures 2,424 mm³, 38.9% below the reference mean. With a Z-score of -2.55 (0.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 16,335 mm³, 9.6% below the reference mean. With a Z-score of -0.83 (20.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,671 mm³, 7.4% below the reference mean. With a Z-score of -0.67 (25.2th percentile), this represents normal volume . ",
  "text_data": "Age is 84.8 years. Gender is Male. Education: 19 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Renal-Genitourinary; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 26.0. Logical Memory: 8.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.90 SUVR (mild reduced); Amyloid beta: 1162.00 pg/mL (normal ); Total tau: 193.00 pg/mL (normal ); Phosphorylated tau: 15.77 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The entorhinal cortex shows significant atrophy (Z-score -2.55, 0.5th percentile), which is a strong biomarker for Alzheimer's pathology, while other brain regions are within normal limits. CSF biomarkers (Aβ, T-tau, P-tau) are normal, and amyloid PET (AV45) shows only mild reduction, suggesting minimal amyloid burden. The MMSE score of 26 is borderline but not definitively impaired.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting biomarkers—entorhinal atrophy suggests neurodegeneration, but CSF and amyloid PET do not strongly support Alzheimer’s pathology)",
  "timestamp": "2025-07-26T01:06:33.365508"
}